Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation–a network meta-analysis of real-world data

M Hirschl, M Kundi - Vasa, 2018 - econtent.hogrefe.com
Background: In randomized controlled trials (RCTs) direct acting oral anticoagulants
(DOACs) showed a superior risk-benefit profile in comparison to vitamin K antagonists …
被引用次数：33 相关文章

Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation-a network meta-analysis of real-world data.

M Hirschl, M Kundi - VASA. Zeitschrift fur Gefasskrankheiten, 2018 - europepmc.org
Background In randomized controlled trials (RCTs) direct acting oral anticoagulants
(DOACs) showed a superior risk-benefit profile in comparison to vitamin K antagonists …

Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation-a network meta-analysis of real-world data

M Hirschl, M Kundi - VASA. Zeitschrift fur …, 2019 - pubmed.ncbi.nlm.nih.gov
Background In randomized controlled trials (RCTs) direct acting oral anticoagulants
(DOACs) showed a superior risk-benefit profile in comparison to vitamin K antagonists …

Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation–a network meta-analysis of real-world data

M Hirschl, M Kundi - Vasa, 2019 - econtent.hogrefe.com
Background: In randomized controlled trials (RCTs) direct acting oral anticoagulants
(DOACs) showed a superior risk-benefit profile in comparison to vitamin K antagonists …